Private philanthropy provides venture capital that is essential to the progress of medical research. Although they are heterogeneous and the support they provide is small in comparison to governmental and industrial support, philanthropic foundations fill a crucial, catalytic niche in medical research, and their involvement in this area should be extended. Foundations and the scientific community should pursue policies augmenting private contributions, and they should educate potential donors a
 |
Total philanthropic giving for 1997 came to $143.46 billion, with $121.89 billion from individuals and bequests, $13.37 billion from noncorporate foundations, and $8.2 billion from corporate foundations. Just over $14 billion, or 8.8 percent of total contributions received by charities, was in the health category. This segment included support of health services and health facilities, such as hospitals and nursing homes; support of ...
Memory-enhancing neural networks may also drive involuntary musical loops in the brain.
View this Issue
In this webinar, Brian Hie will discuss Evo2, a state-of-the-art genomic foundation model capable of generalist prediction and design tasks across DNA, RNA, and proteins.
In this webinar, learn how scientists use advanced human brain models to uncover treatment strategies for complex neurological conditions.
Manufacturing cell-based therapeutics requires a robust workflow from start to finish.
Modern DNA synthesis platforms empower researchers to explore the molecular world, from next-generation sequencing to cell and gene therapy development.
This new product line is specifically engineered to meet the rigorous demands of immunology research, vaccine development, animal studies, cell and gene therapy, and therapeutic protein manufacturing.
New fluidics and clog detection systems further simplify operation and reduce instrument downtime
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies
Study identifies new metrics to enhance scRNA-seq based virtual cell modelling
